This NEJM review article synthesizes the current evidence on beta-blocker use after myocardial infarction, reflecting the paradigm shift from routine long-term therapy to an evidence-based approach where beta-blockers are no longer mandatory when ejection fraction is preserved.
New England Journal of Medicine, Volume 394, Issue 8, Page 820-825, February 19, 2026.
